w******i
发帖数: 1476 | 1 24% increase
LINCOLNSHIRE, Ill. (AP) -- BioSante Pharmaceuticals Inc. said Thursday its
potential pancreatic cancer treatment met key goals in a midstage study.
The company's stock surged 32 cents, or 16 percent, to $2.35 in premarket
trading.
The company said a newly published study showed the vaccine increased the
median survival rate of patients by more than 25 percent to 24.8 months. The
results were published in the February issue of the Annals of Surgery and
involved 60 patients undergoing treatment at the Johns Hopkins Sidney Kimmel
Comprehensive Cancer Center in Baltimore.
The company plans on starting an additional study this year.
The potential prostate cancer drug is part of BioSante's GVAX vaccine
program. It is referred to as a vaccine because it is designed to train a
patient's immune system to fight cancer. A drug using a similar method,
called Provenge, is already made by Dendreon Corp. | s**********9
发帖数: 846 | | s**********9
发帖数: 846 | 3 BioSante Pharmaceuticals (BPAX) To Raise $25.1M In Offering
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) received commitments from
several institutional investors to purchase $25.1 million of securities in a
registered direct offering. BioSante expects to receive ...
Holly crap! | w******i
发帖数: 1476 | | w******i
发帖数: 1476 | 5 24% increase
LINCOLNSHIRE, Ill. (AP) -- BioSante Pharmaceuticals Inc. said Thursday its
potential pancreatic cancer treatment met key goals in a midstage study.
The company's stock surged 32 cents, or 16 percent, to $2.35 in premarket
trading.
The company said a newly published study showed the vaccine increased the
median survival rate of patients by more than 25 percent to 24.8 months. The
results were published in the February issue of the Annals of Surgery and
involved 60 patients undergoing treatment at the Johns Hopkins Sidney Kimmel
Comprehensive Cancer Center in Baltimore.
The company plans on starting an additional study this year.
The potential prostate cancer drug is part of BioSante's GVAX vaccine
program. It is referred to as a vaccine because it is designed to train a
patient's immune system to fight cancer. A drug using a similar method,
called Provenge, is already made by Dendreon Corp. | s**********9
发帖数: 846 | | s**********9
发帖数: 846 | 7 BioSante Pharmaceuticals (BPAX) To Raise $25.1M In Offering
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) received commitments from
several institutional investors to purchase $25.1 million of securities in a
registered direct offering. BioSante expects to receive ...
Holly crap! | w******i
发帖数: 1476 | |
|
